⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

January 1, 2013World Journal of HematologyOpen Access

PVSG and WHOvsEuropean Clinical, Molecular and Pathological Criteria for prefibrotic myeloproliferative neoplasms

View Full Paper

Ask AI

Bookmark

Share

Abstract

PVSG and WHO vs European Clinical, Molecular and Pathological Criteria for prefibrotic myeloproliferative neoplasms

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Jan Michiels (2013) studied this question.

synapsesocial.com/papers/6a86d8017fdf9298f89eb842 https://doi.org/10.5315/wjh.v2.i3.71

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Multifaceted role of haptoglobin: Implications for disease developmentWorld Journal of Hematology · Thu,
2Involvement of haptoglobin in disease developmentWorld Journal of Hematology · Fri,
3COVID-19 impact in Crohn’s disease patients submitted to autologous hematopoietic stem cell transplantationWorld Journal of Hematology · Mon,
4Role of hematological parameters in pathogenesis of diabetes mellitus: A review of the literatureWorld Journal of Hematology · Wed,
5Advantageous tactics with certain probiotics for the treatment of graft-versus-host-disease after hematopoietic stem cell transplantationWorld Journal of Hematology · Mon,

More from World Journal of Hematology

Venous thromboembolism prophylaxis of a patient with MYH-9 related disease and COVID-19 infection: A case reportWed,
Allogeneic stem cell transplantation in chronic myeloid leukemia patients: Single center experienceSun,
Aspirin cures erythromelalgia and cerebrovascular disturbances in JAK2-thrombocythemia through platelet-cycloxygenase inhibitionSun,
Current approach to disseminated intravascular coagulation related to sepsis - organ failure typeSun,
Role of plasmapheresis in early allograft dysfunction following deceased donor liver transplantationSun,